Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-10

Clinical Trial Update: Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating transplantation of autologous oral mucosal epithelial stem cell sheets to treat limbal stem cell deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous oral mucosal epithelial stem cell sheet

Snippet

Sponsor: He Eye Hospital | Conditions: Limbal Stem Cell Deficiency | Phase 1, Phase 2 | Status: UNKNOWN